Skip to content
PubMed This is a summary of 56 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 56 referenced papers

Top Authors

Bernard Brais
Montreal Neurological Institute and Hospital
David Pellerin
Montreal Neurological Institute and Hospital
Matthis Synofzik
German Center for Neurodegenerative Diseases
Stephan L. Zuchner
University of Miami
Matt Christopher Danzi
University of Miami
Marie‐Josée Dicaire
Montreal Neurological Institute and Hospital
Henry Houlden
National Hospital for Neurology and Neurosurgery
Marion Wandzel
Centre Hospitalier Régional et Universitaire de Nancy

Top Institutions

Ranked by publications Top 10 institutions
09

Centre Hospitalier Régional et Universitaire de Nancy

Nancy, France

13 papers

References

References (56)
  1. 1

    Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

    Richards S, Aziz N, Bale S, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2015; (17(5)):405-24 doi:10.1038/gim.2015.30.

    PMID: 25741868
  2. 2

    Intracellular FGF14 (iFGF14) Is Required for Spontaneous and Evoked Firing in Cerebellar Purkinje Neurons and for Motor Coordination and Balance.

    Bosch MK, Carrasquillo Y, Ransdell JL, et al.

    The Journal of neuroscience : the official journal of the Society for Neuroscience 2015; (35(17)):6752-69 doi:10.1523/JNEUROSCI.2663-14.2015.

    PMID: 25926453
  3. 3

    The effect of a task-specific locomotor training strategy on gait stability in patients with cerebellar disease: a feasibility study.

    Im SJ, Kim YH, Kim KH, et al.

    Disability and rehabilitation 2017; (39(10)):1002-1008 doi:10.1080/09638288.2016.1177124.

    PMID: 27216372
  4. 4

    Acetazolamide-Responsive Episodic Ataxia Linked to Novel Splice Site Variant in FGF14 Gene.

    Schesny M, Joncourt F, Tarnutzer AA

    Cerebellum (London, England) 2019; (18(3)):649-653 doi:10.1007/s12311-018-0997-3.

    PMID: 30607796
  5. 5

    Clinical and genetic spectrum of SCN2A-associated episodic ataxia.

    Schwarz N, Bast T, Gaily E, et al.

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2019; (23(3)):438-447 doi:10.1016/j.ejpn.2019.03.001.

    PMID: 30928199
  6. 6

    High-throughput screening against protein:protein interaction interfaces reveals anti-cancer therapeutics as potent modulators of the voltage-gated Na+ channel complex.

    Wadsworth PA, Folorunso O, Nguyen N, et al.

    Scientific reports 2019; (9(1)):16890 doi:10.1038/s41598-019-53110-8.

    PMID: 31729429
  7. 7

    FGF14-related episodic ataxia: delineating the phenotype of Episodic Ataxia type 9.

    Piarroux J, Riant F, Humbertclaude V, et al.

    Annals of clinical and translational neurology 2020; (7(4)):565-572 doi:10.1002/acn3.51005.

    PMID: 32162847
  8. 8

    Video quality using outpatient smartphone videos in epilepsy: Results from the OSmartViE study.

    Tatum WO, Hirsch LJ, Gelfand MA, et al.

    European journal of neurology 2021; (28(5)):1453-1462 doi:10.1111/ene.14744.

    PMID: 33465822
  9. 9

    Amelioration of motor and nonmotor symptoms in cortical cerebellar atrophy and multiple system atrophy-cerebellar type by inpatient rehabilitation: a retrospective study.

    Sonoda Y, Yamanaka Y, Sawano S, et al.

    International journal of rehabilitation research. Internationale Zeitschrift fur Rehabilitationsforschung. Revue internationale de recherches de readaptation 2021; (44(2)):104-109 doi:10.1097/MRR.0000000000000455.

    PMID: 33481455
  10. 10

    Epilepsy and episodic ataxia type 2: family study and review of the literature.

    Verriello L, Pauletto G, Nilo A, et al.

    Journal of neurology 2021; (268(11)):4296-4302 doi:10.1007/s00415-021-10555-0.

    PMID: 33983550
  11. 11

    Fampridine and Acetazolamide in EA2 and Related Familial EA: A Prospective Randomized Placebo-Controlled Trial.

    Muth C, Teufel J, Schöls L, et al.

    Neurology. Clinical practice 2021; (11(4)):e438-e446 doi:10.1212/CPJ.0000000000001017.

    PMID: 34484942
  12. 12

    The Clinical Value of Patient Home Videos in Movement Disorders.

    Billnitzer A, Jankovic J

    Tremor and other hyperkinetic movements (New York, N.Y.) 2021; (11()):37 doi:10.5334/tohm.651.

    PMID: 34692230
  13. 13

    Update on diagnosis and differential diagnosis of vestibular migraine.

    Shen Y, Qi X

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2022; (43(3)):1659-1666 doi:10.1007/s10072-022-05872-9.

    PMID: 35015204
  14. 14

    Genetic paroxysmal neurological disorders featuring episodic ataxia and epilepsy.

    Amadori E, Pellino G, Bansal L, et al.

    European journal of medical genetics 2022; (65(4)):104450 doi:10.1016/j.ejmg.2022.104450.

    PMID: 35219921
  15. 15

    Neuroimaging in cerebellar ataxia in childhood: A review.

    Serrallach BL, Orman G, Boltshauser E, et al.

    Journal of neuroimaging : official journal of the American Society of Neuroimaging 2022; (32(5)):825-851 doi:10.1111/jon.13017.

    PMID: 35749078
  16. 16

    Episodic ataxia type 2 (EA2) with interictal myokymia and focal dystonia.

    Nielsen EN, Ásbjörnsdóttir B, Møller LB, et al.

    Cold Spring Harbor molecular case studies 2022; (8(6)) doi:10.1101/mcs.a006236.

    PMID: 36307210
  17. 17

    Episodic Ataxias: Primary and Secondary Etiologies, Treatment, and Classification Approaches.

    Hassan A

    Tremor and other hyperkinetic movements (New York, N.Y.) 2023; (13()):9 doi:10.5334/tohm.747.

    PMID: 37008993
  18. 18

    GAA-FGF14 ataxia (SCA27B): phenotypic profile, natural history progression and 4-aminopyridine treatment response.

    Wilke C, Pellerin D, Mengel D, et al.

    Brain : a journal of neurology 2023; (146(10)):4144-4157 doi:10.1093/brain/awad157.

    PMID: 37165652
  19. 19

    Optimized testing strategy for the diagnosis of GAA-FGF14 ataxia/spinocerebellar ataxia 27B.

    Bonnet C, Pellerin D, Roth V, et al.

    Scientific reports 2023; (13(1)):9737 doi:10.1038/s41598-023-36654-8.

    PMID: 37322040
  20. 20

    Pearls & Oy-sters: ATX-FGF14 Mimicking Autoimmune Pathology.

    Hoshina Y, Wright MA, Warner JEA, et al.

    Neurology 2023; (101(14)):e1478-e1482 doi:10.1212/WNL.0000000000207590.

    PMID: 37460234
  21. 21

    Frequency and phenotypic spectrum of spinocerebellar ataxia 27B and other genetic ataxias in a Spanish cohort of late-onset cerebellar ataxia.

    Iruzubieta P, Pellerin D, Bergareche A, et al.

    European journal of neurology 2023; (30(12)):3828-3833 doi:10.1111/ene.16039.

    PMID: 37578187
  22. 22

    Video Recording Patients for Direct Care Purposes: Systematic Review and Narrative Synthesis of International Empirical Studies and UK Professional Guidance.

    Lear R, Ellis S, Ollivierre-Harris T, et al.

    Journal of medical Internet research 2023; (25()):e46478 doi:10.2196/46478.

    PMID: 37585249
  23. 23

    Clinical and genetic keys to cerebellar ataxia due to FGF14 GAA expansions.

    Méreaux JL, Davoine CS, Pellerin D, et al.

    EBioMedicine 2024; (99()):104931 doi:10.1016/j.ebiom.2023.104931.

    PMID: 38150853
  24. 24

    Paroxysmal Ataxia: A Characteristic Feature of FGF14 Repeat Expansion (SCA27B).

    Foucard C, Belley M, Sangare A, et al.

    Neurology. Genetics 2024; (10(1)):e200118 doi:10.1212/NXG.0000000000200118.

    PMID: 38170134
  25. 25

    Effectiveness and cost of integrated cognitive and balance training for balance and falls in cerebellar ataxia: a blinded two-arm parallel group RCT.

    Winser SJ, Chan AYY, Whitney SL, et al.

    Frontiers in neurology 2023; (14()):1267099 doi:10.3389/fneur.2023.1267099.

    PMID: 38313407
  26. 26

    The episodic ataxias.

    Graves TD, Snell HD, Khodakhah K, et al.

    Handbook of clinical neurology 2024; (203()):123-133 doi:10.1016/B978-0-323-90820-7.00012-4.

    PMID: 39174244
  27. 27

    Identification and characterisation of pathogenic and non-pathogenic FGF14 repeat expansions.

    Mohren L, Erdlenbruch F, Leitão E, et al.

    Nature communications 2024; (15(1)):7665 doi:10.1038/s41467-024-52148-1.

    PMID: 39227614
  28. 28

    Clinical, Radiological and Pathological Features of a Large American Cohort of Spinocerebellar Ataxia (SCA27B).

    Abou Chaar W, Eranki AN, Stevens HA, et al.

    Annals of neurology 2024; (96(6)):1092-1103 doi:10.1002/ana.27060.

    PMID: 39263992
  29. 29

    Spinocerebellar Ataxia Type 27B (SCA27B): A Hereditary Ataxia in Portugal.

    Mendes Ferreira V, Magriço M, Meira B, Barbosa R

    Acta medica portuguesa 2025; (38(6-7)):408-411 doi:10.20344/amp.22232.

    PMID: 39392764
  30. 30

    In Vivo Expression of an SCA27A-linked FGF14 Mutation Results in Haploinsufficiency and Impaired Firing of Cerebellar Purkinje Neurons.

    Ransdell JL, Brown SP, Xiao M, et al.

    bioRxiv : the preprint server for biology 2024; doi:10.1101/2024.10.25.620253.

    PMID: 39484407
  31. 31

    Goal-Directed Rehabilitation Versus Standard Care for Individuals with Hereditary Cerebellar Ataxia: A Multicenter, Single-Blind, Randomized Controlled Superiority Trial.

    Milne SC, Roberts M, Williams S, et al.

    Annals of neurology 2025; (97(3)):409-424 doi:10.1002/ana.27130.

    PMID: 39520242
  32. 32

    How to distinguish spinocerebellar ataxia 27B from late onset cerebellar ataxia: insights from a case-control study.

    Pinheiro-Barbosa R, Cissé C, Bastos P, et al.

    Journal of neurology 2024; (272(1)):45 doi:10.1007/s00415-024-12738-x.

    PMID: 39666053
  33. 33

    Effects of physiotherapy on degenerative cerebellar ataxia: a systematic review and meta-analysis.

    Matsugi A, Bando K, Kondo Y, et al.

    Frontiers in neurology 2024; (15()):1491142 doi:10.3389/fneur.2024.1491142.

    PMID: 39866519
  34. 34

    Spinocerebellar ataxia 27B (SCA27B)-a systematic review and a case report of a Polish family.

    Hirschfeld AS, Misiorek JO, Dabrowska M, et al.

    Journal of applied genetics 2025; (66(4)):895-902 doi:10.1007/s13353-025-00967-3.

    PMID: 40299270
  35. 35

    FGF14 repeat length and mosaic interruptions: modifiers of spinocerebellar ataxia 27B?

    Laß J, Thomsen M, Borsche M, et al.

    Brain : a journal of neurology 2025; (148(11)):4072-4083 doi:10.1093/brain/awaf183.

    PMID: 40379261
  36. 36

    Video-Oculography as a Key Diagnostic Tool for SCA27B: A Real-Life Experience.

    Coulette S, Lecler A, Le Cossec C, et al.

    European journal of neurology 2025; (32(6)):e70228 doi:10.1111/ene.70228.

    PMID: 40556471
  37. 37

    Spinocerebellar Ataxia Type 27B can be Suspected Based on Clinical Phenotype: The Massachusetts General Hospital Ataxia Center Experience.

    Rettenmaier LA, Chen JYH, MacMore J, et al.

    Cerebellum (London, England) 2025; (24(5)):133 doi:10.1007/s12311-025-01882-3.

    PMID: 40679574
  38. 38

    Causes of Diplopia, Strabismus Patterns, and Ocular Motor Features in Patients With Spinocerebellar Ataxia Type 27B.

    Gold DR, Bery AK, Moukheiber E, et al.

    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 2026; (46(1)):73-80 doi:10.1097/WNO.0000000000002364.

    PMID: 40693779
  39. 39

    A journey through genetic movement disorders caused by non-coding repeat expansions.

    da Hora RPC, Rossi M, Procaci VR, et al.

    Parkinsonism & related disorders 2025; (138()):107967 doi:10.1016/j.parkreldis.2025.107967.

    PMID: 40701895
  40. 40

    Prevalence, Severity, and Progression of Cerebellar Cognitive-Affective Syndrome in Patients With Spinocerebellar Ataxias.

    Petit E, López Domínguez D, Marelli C, et al.

    Neurology 2025; (105(5)):e213980 doi:10.1212/WNL.0000000000213980.

    PMID: 40834346
  41. 41

    Practice Recommendations for Genetic Testing of Ataxias.

    Srinivasan SR, Mook AD, Rochman M, et al.

    Annals of clinical and translational neurology 2025; (12(12)):2398-2409 doi:10.1002/acn3.70171.

    PMID: 40883955
  42. 42

    Ocular Motor and Vestibular Profile in Spinocerebellar Ataxia Type 27B: Toward a Practical Bedside Diagnostic Framework.

    Ariello LE, Gold DR, Mu W, et al.

    Cerebellum (London, England) 2025; (24(5)):149 doi:10.1007/s12311-025-01906-y.

    PMID: 40906330
  43. 43

    Delineating the pathogenic threshold and phenotypic spectrum of SCA27B: findings from a large French-Canadian cohort.

    Iruzubieta P, Pellerin D, Ashton C, et al.

    Journal of neurology 2025; (272(9)):636 doi:10.1007/s00415-025-13387-4.

    PMID: 40974444
  44. 44

    Clinical characteristics, cerebellar MR spectroscopy and response to 3,4-diaminopyridine in spinocerebellar ataxia 27B: the Sheffield Ataxia Centre experience.

    Chukwuocha I, Pellerin D, Shanmugarajah P, et al.

    Journal of neurology 2025; (272(10)):681 doi:10.1007/s00415-025-13422-4.

    PMID: 41065930
  45. 45

    Clinical, Genetic, and Imaging Characteristics of SCA27B: Insights from a Large Dutch Cohort.

    van Prooije TH, Pennings M, Maas RPPWM, et al.

    Movement disorders : official journal of the Movement Disorder Society 2026; (41(4)):928-936 doi:10.1002/mds.70190.

    PMID: 41504274
  46. 46

    In Vivo Expression of an SCA27A-Linked FGF14 Mutation Results in Haploinsufficiency and Impaired Firing of Cerebellar Purkinje Neurons.

    Ransdell JL, Brown SP, Xiao M, et al.

    The Journal of neuroscience : the official journal of the Society for Neuroscience 2026; (46(7)) doi:10.1523/JNEUROSCI.2016-24.2026.

    PMID: 41558966
  47. 47

    Pearls & Oy-sters: SCA27B as an Elusive Genetic Cause of Episodic Neurologic Symptoms in Later Adulthood.

    Yomtoob J, Morse L, Keller Sarmiento IJ, et al.

    Neurology 2026; (106(6)):e214754 doi:10.1212/WNL.0000000000214754.

    PMID: 41698164
  48. 48

    Clinicopathologic Correlates: Progressive Downbeat Nystagmus in Spinocerebellar Ataxia Type 27B.

    Hale DE, Mu W, Gold DR

    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 2026; (46(1)):113-116 doi:10.1097/WNO.0000000000002452.

    PMID: 41700956
  49. 49

    Clinical and Genetic Characteristics of SCA27B: A Global Systematic Review and Meta-Analysis.

    Mustafa F, Agarwal A, Garg A, et al.

    Cerebellum (London, England) 2026; (25(4)).

    PMID: 42360552
  50. 50

    Phenotype and Genetics of Spinocerebellar Ataxia Type 27B: Novel Movement-disorder Features, Cognitive Impairment, and Repeat Expansion Findings.

    Rashedi R, Peemöller F, Erdmann H, et al.

    Cerebellum (London, England) 2026; (25(4)).

    PMID: 42371259
  51. 51

    Cerebellar cognitive affective syndrome (CCAS) and [18F]-FDG PET findings in spinocerebellar ataxia type SCA27B.

    Cros L, Pellerin D, Palpacuer T, et al.

    Journal of neurology 2026; (273(8)).

    PMID: 42481725
  52. 52

    Downbeat Nystagmus and Saccadic Oscillations in Spinocerebellar Ataxia Type 27B: A 14-Month Follow-Up Case Report.

    Skacik P, Koprusakova MT, Sivak S, et al.

    Case reports in neurology 2026; (18(1)):436-441 doi:10.1159/000552966.

    PMID: 42569714
  53. 53

    Longitudinal progression, metrics, age-dependence, and modifiers of ataxia severity in SCA27B: a multicentre study of 219 patients.

    Traschütz A, Hilgers RD, Erdlenbruch F, et al.

    EBioMedicine 2026; (131()):106437 doi:10.1016/j.ebiom.2026.106437.

    PMID: 42603514
  54. 54

    Characteristics of a Cohort of Individuals With SCA27B Associated With Repeat Expansions in FGF14.

    Anderson SC, Patel SG, Rodrigues M, et al.

    Neurology. Genetics 2026; (12(5)):e200424 doi:10.1212/NXG.0000000000200424.

    PMID: 42699715
  55. 55

    Vertigo and dizziness syndromes in children and adolescents: Clinical presentation and diagnostic pathway.

    Huppert D, Strobl R, Zwergal A, et al.

    Developmental medicine and child neurology 2026; doi:10.1111/dmcn.70506.

    PMID: 42745351
  56. 56

    Taking a clinical history in adolescents and adults presenting with seizures or epilepsy.

    Gaitatzis A, Beniczky S, Sander JW, et al.

    Epileptic disorders : international epilepsy journal with videotape 2026; doi:10.1002/epd2.70368.

    PMID: 42858167